Inventory

12 Months Ended

Dec. 31, 2021

Inventory Disclosure [Abstract]

Inventory

Inventory

Components of inventory, net of reserves as of December 31, 2021 and 2020 are as follows (table in thousands):

	December 31, 2021		December 31, 2020
Raw Materials	$	3,434	$	3,112
Work in Process	201		172
Finished Goods	1,964		1,805
Total	$	5,599	$	5,089

As of December 31, 2021 and 2020, the Company classified $1.5 million and $1.2 million, respectively, of inventory as non-current all of which was related to Triferic or the active pharmaceutical ingredient for Triferic. As of December 31, 2021 and 2020, Rockwell had total Triferic inventory aggregating $1.7 million and $3.9 million, respectively, against which Rockwell had reserved $0.1 million and $2.6 million, respectively.

The $1.6 million net value of Triferic inventory consisted of $0.3 million of Triferic (dialysate) finished goods with expiration dates ranging from July 2022 to December 2023, $0.4 million of Triferic API with estimated useful lives extending through 2023, and $0.9 million of Triferic raw material with an estimated useful live of 25 years.